DOL OIG Audit The JOB CORPS.: HOLY MOLY!! WHAT!?!? WHY? ➡This dramatic increase was due almost exclusively to the rise in reported costs for compounded drugs, which jumped from approximately $2 million in FY 2011 to $263 million in FY 2016, an increase of more than a hundredfold!!!
Semiannual Report to Congress, October 1, 2017 – March 31, 2018,
Office of Inspector General, Department of the Treasury